4.8 Article

Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase

期刊

NATURE MEDICINE
卷 15, 期 3, 页码 338-344

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nm.1930

关键词

-

资金

  1. US National Institutes of Health [CA95152, CA059350, CA08748, CA086438, CA096945, CA094060, CA083084]
  2. Alliance for Cancer Gene Therapy
  3. Damon Runyon Clinical Investigator Award
  4. Canada Club of New York, Kate's Team
  5. Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of MSKCC
  6. Geoffrey Beene Cancer Foundation
  7. Chronic Lymphocytic Leukemia Foundation
  8. Ludwig Center for Cancer Immunotherapy
  9. Bocina Cancer Research Fund

向作者/读者索取更多资源

We developed a new approach to bioluminescent T cell imaging using a membrane-anchored form of the Gaussia luciferase (GLuc) enzyme, termed extGLuc, which we could stably express in both mouse and human primary T cells. In vitro, extGLuc(+) cells emitted significantly higher bioluminescent signal when compared to cells expressing GLuc, Renilla luciferase (RLuc) or membrane-anchored RLuc (extRLuc). In vivo, mouse extGLuc(+) T cells showed higher bioluminescent signal when compared to GLuc(+) and RLuc(+) T cells. Application of this imaging approach to human T cells genetically modified to express tumor-specific chimeric antigen receptors (CARs) enabled us to show in vivo CAR-mediated T cell accumulation in tumor, T cell persistence over time and concomitant imaging of T cells and tumor cells modified to express firefly luciferase. This sensitive imaging technology has application to many in vivo cell-based studies in a wide array of mouse models.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据